azepinomycin

ID: ALA2203870

Chembl Id: CHEMBL2203870

Cas Number: 89354-15-4

PubChem CID: 128950

Max Phase: Preclinical

Molecular Formula: C6H8N4O2

Molecular Weight: 168.16

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Azepinomycin | Azepinomycin|89354-15-4|CHEMBL2203870|6-hydroxy-4,5,6,7-tetrahydroimidazo[4,5-e][1,4]diazepin-8(1h)-one|4,5,6,7-Tetrahydro-6-hydroxy-3H-imidazo-(4,5e)(1,4)diazepin-8-one|starbld0002815|DTXSID901008765|6-hydroxy-4,5,6,7-tetrahydro-1H-imidazo[4,5-e][1,4]diazepin-8-one|BDBM50401837|3,4,5,6-Tetrahydroimidazo[4,5-e][1,4]diazepine-6,8-diol|Imidazo(4,5-e)(1,4)diazepin-8(1H)-one, 4,5,6,7-tetrahydro-6-hydroxy-

Canonical SMILES:  O=C1NC(O)CNc2nc[nH]c21

Standard InChI:  InChI=1S/C6H8N4O2/c11-3-1-7-5-4(6(12)10-3)8-2-9-5/h2-3,7,11H,1H2,(H,8,9)(H,10,12)

Standard InChI Key:  HCLYCONTUAROEE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA2203870

    AZEPINOMYCIN

Associated Targets(Human)

GDA Tbio Guanine deaminase (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 168.16Molecular Weight (Monoisotopic): 168.0647AlogP: -1.12#Rotatable Bonds:
Polar Surface Area: 90.04Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 13.38CX Basic pKa: 4.15CX LogP: -0.97CX LogD: -0.97
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.39Np Likeness Score: 0.60

References

1. Chakraborty S, Shah NH, Fishbein JC, Hosmane RS..  (2012)  Investigations into specificity of azepinomycin for inhibition of guanase: discrimination between the natural heterocyclic inhibitor and its synthetic nucleoside analogues.,  22  (23): [PMID:23084905] [10.1016/j.bmcl.2012.09.053]
2. Tantravedi S, Chakraborty S, Shah NH, Fishbein JC, Hosmane RS..  (2013)  Analogs of iso-azepinomycin as potential transition-state analog inhibitors of guanase: synthesis, biochemical screening, and structure-activity correlations of various selectively substituted imidazo[4,5-e][1,4]diazepines.,  21  (17): [PMID:23891230] [10.1016/j.bmc.2013.06.069]

Source